Eli Lilly and Company (LLY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous close | 298.85 |
| Open | 300.60 |
| Bid | 301.50 x 800 |
| Ask | 301.70 x 1100 |
| Day's range | 299.35 - 304.92 |
| 52-week range | 195.50 - 314.00 |
| Volume | |
| Avg. volume | 2,966,870 |
| Market cap | 287.518B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 44.98 |
| EPS (TTM) | 6.73 |
| Earnings date | 04 Aug 2022 |
| Forward dividend & yield | 3.92 (1.31%) |
| Ex-dividend date | 13 May 2022 |
| 1y target est | 304.28 |
- PR Newswire
Lilly Announces Webcast to Provide Diabetes and Obesity Portfolio Update at ADA
Eli Lilly and Company (NYSE: LLY) will host a webcast on Tuesday, June 7, 2022 to discuss the company's diabetes and obesity portfolio and its presentations at the American Diabetes Association's 82nd Scientific Sessions. The webcast will begin at 11:30 a.m. Eastern time and remarks will focus on results from the tirzepatide SURMOUNT-1 clinical trial, as well as Lilly's once-weekly basal insulin and early-phase incretins.
- Zacks
Lilly's (LLY) Olumiant Gets CHMP Nod for Alopecia Areata
The CHMP gives a positive opinion and recommends approval of Lilly's (LLY) Olumiant to treat adults with severe alopecia areata.
© 2022 Yahoo. All rights reserved.
